Strides Pharma Science Ltd.
|BSE: 532531||Sector: Health care|
|NSE: STAR||ISIN Code: INE939A01011|
|BSE 00:00 | 22 Sep||659.35||
|NSE 00:00 | 22 Sep||658.25||
|Mkt Cap.(Rs cr)||5,910|
|Mkt Cap.(Rs cr)||5909.75|
Strides Pharma Science Ltd. (STAR) - Latest News & Headlines
3.17 pm | 11 Sep 2020 | Business Standard
The company reported strong performance across all businesses in Q1FY21 despite significant disruptions and ambiguity in the business environment due ...
2.01 pm | 21 Aug 2020 | Business Standard
The stocks trading above the 200-DMA are usually in a bullish phase. Here is the complete list
11.55 am | 21 Aug 2020 | Business Standard
Ursodiol is used for treatment of patients with primary biliary cirrhosis (PBC)
11.35 pm | 7 Aug 2020 | Business Standard
In a Q&A, pharma major's MD & CEO, R Ananthanarayanan says the firm is setting up a vaccine suite and is in final-stage talks with global players to s...
12.06 pm | 21 May 2020 | Business Standard
Favipiravir is manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug in th...
2.20 am | 21 May 2020 | Business Standard
Ranitidine was a $9 million business for Strides in the first half of FY20
12.52 am | 30 Apr 2020 | Business Standard
Firm says will apply to Indian pharma authorities to start studies
10.29 am | 29 Apr 2020 | Business Standard
The drug has demonstrated positive outcomes, including a reduction in the duration of Covid-19 and improved lung conditions for the patients